Navigation Links
Acclarent, Inc. Closes $26 Million Financing
Date:1/11/2009

MENLO PARK, Calif., Jan. 12 /PRNewswire/ -- Acclarent, Inc., a leading medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat, announced today the closing of a $26 million dollar financing round. Acclarent intends to use the proceeds to continue commercialization of its Balloon Sinuplasty(TM) Technology, as well as on-going investment in product development and clinical studies.

Johnson & Johnson Development Corporation (JJDC) joined existing prominent investors New Enterprise Associates, Inc., Delphi Ventures, Versant Ventures, and Meritech Capital Partners in this financing.

"The addition of JJDC together with the support of our existing financial partners will enable Acclarent to continue executing on our strategy to build the preeminent ENT Company," said Bill Facteau, Acclarent President and CEO.

About Johnson & Johnson Development Corporation. Organized in 1973, Johnson & Johnson Development Corporation is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. For more information, go to http://www.jjdevcorp.com.

About Acclarent, Inc.

Acclarent is a medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat. The company is currently focused on commercializing its Balloon Sinuplasty(TM) Devices, which are flexible, minimally-invasive tools that aid physicians in treating patients suffering from chronic sinusitis.


'/>"/>
SOURCE Acclarent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
2. Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing
3. Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
4. Oaks Development Group Closes on Third San Antonio Project
5. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
6. Morgenthaler Closes Ninth Fund at $400 Million
7. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
8. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
9. Response Biomedical Closes $5.1 Million Financing
10. Blue Cross Blue Shield of Michigan Closes Detroit Operations October 31 Due to Bomb Threat
11. Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: